We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Outcomes of Drugs and Vitamins in Treating Heart Disease

By HospiMedica staff writers
Posted on 05 Dec 2001
A study has demonstrated that treatment with a combination of statin and niacin can slash the risk of a fatal or nonfatal heart attack and/or death from coronary heart disease by 60-90%. More...
Another finding was that antioxidant vitamins had no beneficial effect on the outcomes. Conducted by researchers at the University of Washington (Seattle, USA; www.washington.edu), the study was published in the November 29, 2001, issue of The New England Journal of Medicine.

Treatment with a statin drug was found to lower levels of low density lipoprotein (LDL) by 43%, while the use of niacin was found to boost levels of high density lipoprotein (HDL) by 26%. The study found that this combined treatment in people with low levels of HDL and average levels of LDL also decreased plaque buildup. In spite of some prior evidence that antioxidant vitamins could protect against cholesterol buildup, the study showed that people who took vitamins C, E, beta carotene, and selenium received no cardiovascular benefit. Instead, these vitamins were found to blunt the expected rise in HDL cholesterol usually resulting from treatment with statin and niacin. The researchers are uncertain as to the cause.

In another recent trial, the use of certain other vitamins was found to prevent repeat blockage of the coronary artery after angioplasty. Conducted by researchers at the University of California, San Diego (CA, USA), in collaboration with the Swiss Cardiovascular Center (Bern), this study was also published in the November 29, 2001, issue of The New England Journal of Medicine.

The researchers found that patients who took one milligram of folic acid, 400 micrograms of vitamin B-12, and 10 milligrams of vitamin B-6, the risk of restenosis dropped 48%. It has been known that these vitamins lower homocysteine levels and that slightly elevated homocysteine levels are associated with an increased risk of heart disease, but this is the first clinical trial to examine the effects of these vitamins on heart disease.

"This has proven to be a very effective and inexpensive treatment for preventing coronary restenosis,” said Guido Schnyder, M.D., a UCSD cardiologist and visiting scholar from Switzerland who led the vitamin study.



Related Links:
Univ. of Washington
Univ. of California, San Diego

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.